SuperNus Pharma Raises $35 Million

By PEHub Administrator — 6 years ago

Supernus Pharmaceuticals Inc., a Rockville, Md.-based developer of CNS products, has raised around $35 million in its second non-dilutive financing round. Last April, it had announced a $75 million transaction secured by royalties generated from partnered products using Supernus technologies. The company in 2006 raised $45 million in venture capital from firms like Abingworth Management, New Enterprise Associates and OrbiMed Advisors.